There was intense press interest for a recent policy paper in PLoS Medicine called "Following the Script: How Drug Reps Make Friends…
-
post A Registry of Journals Free of Drug Ads?
-
post PLoS Talks At Harvard: Human Rights, Social Sciences
I was kindly invited to give two talks about open access at Harvard University, and both are now available online. The first…
-
post Guest Blog by Oliver Morgan: The Impact of Concurrent Humanitarian Disasters
The open access publisher Biomed Central has just launched a new journal called Conflict and Health. We asked Oliver Morgan, Honorary Research…
-
post Guest Blog: Jean-René Kiechel & Bernard Pecoul of www.dndi.org
On March 1st 2007 the Drugs for Neglected Diseases initiative (DNDi) and Sanofi-Aventis are hosting a round table discussion to celebrate the…
-
post Why Open Access Matters to the Public
As Chris Surridge, Managing Editor of PLoS ONE, mentioned in his recent blog, the science journalist and medical doctor Ben Goldacre has…
-
post Time to End the Slavery of Traditional Publishing
In a characteristically provocative talk last week, Richard Smith, who is on the Board of Directors of PLoS, accused traditional subscription-based publishers…
-
post PLoS Neglected Tropical Diseases: Open for Submissions
In 2002, I wrote an editorial called "The world's most neglected diseases," in which I painted a bleak picture of the outlook…
-
post A Call for Papers on Poverty and Human Development
In October 2007, PLoS Medicine will publish a special issue devoted to poverty and human development. As I discussed in a previous…
-
post How Much Should the Rich Give to the Poor?
The world’s poorest countries will not reach the Millennium Development Goals (MDGs) unless they receive additional financing to fund their often-weak health…
-
post Open Access 101: The Video
If you're looking for a primer on open access publishing –the benefits and challenges–you may be interested in watching a video recording…
-
post Getting Serious About Global AIDS Control
In their influential paper in The Lancet in 2001, Jeffrey Sachs (nominated by Time Magazine as one of the 100 most important…
-
post Announcing PLoS Neglected Tropical Diseases
"It is no longer possible to say that people aren’t trying hard enough, or thinking creatively enough, to solve the problem of…